La Vista, NE – The trusted cell stability technology of Streck, Inc.’s glass Cell-Free DNA BCT® and Cyto-Chex® BCT is now available in the Fusion2TM plastic blood collection tube. Streck has partnered with SiO2 Medical Products, Inc., a manufacturer of high quality pharmaceutical and medical device components, for the customization and manufacture of the unique hybrid plastic […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) announced today that it has acquired all of the stock of Trevigen Inc. for cash. The transaction is financed through available cash on hand. Charles R. Kummeth, President and Chief Executive Officer of Bio-Techne, commented, “We are pleased to have Trevigen as part of Bio-Techne Corporation. We are very familiar […]
SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Anthem has issued a positive coverage decision for the Prosigna® Breast Cancer Gene Signature Assay. This positive coverage decision is in line with updated ASCO guidelines released in February 2016. The ASCO guidelines recommend the use of […]
CellSystems and ATERA to expand their on-going collaboration by co-marketing ATERA’s ‘on demand’ advanced 3D-tissue model R&D and specialized contract research services. On July 3, 2017, CellSystems Biotechnologie Vertrieb GmbH (Troisdorf, Germany) and ATERA SAS (Sophia Antipolis, France) announced a close collaboration for the commercialization of the epiCS® human skin models, including human epidermis, tanned epidermis and full thickness skin. […]
M2’s Scientists to Leverage PerkinElmer’s Robotic Cellular Screening Workstations for Insights into Materials and BioMedical Sciences WHAT: PerkinElmer, Inc. a global leader committed to innovating for a healthier world, today announced that researchers at Australia’s new M2 medtech R&D initiative will utilize its cell::explorer™ robotic workstations for cell cultivation and phenotypic screening. WHEN & WHERE: […]
AMSBIO announces the availability of StemFit® Basic02 feeder-free stem cell culture media. Stem cells and genome editing offer exciting opportunities within regenerative medicine. However, any clinical application of stem cells requires strict regulation to ensure that the cells are not exposed to animal derived products. StemFit® Basic02 is a xeno-free, defined medium for human pluripotent stem […]
Kymriah™ (tisagenlecleucel, formerly CTL019), the first FDA-approved CAR-T cell therapy, uses CTS Dynabeads CD3/CD28 spherical beads to isolate, activate and expand T cells WALTHAM, Mass. — The U.S. Food and Drug Administration (FDA) has approved a new cell therapy for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia […]
Seattle, WA – RareCyte, Inc., a global rare cell detection and liquid biopsy company will use the funding to advance its commercial sales efforts and build companion diagnostics (CDx) programs with strategic partners. The Company will also expand its regulatory infrastructure and research and development efforts. The $30M investment was led by 5AM Ventures with participation from […]
Notable private equity firm invests £2.5 million in the Cambridge-based biotech Private equity firm Calculus Capital, a leading EIS and VCT investor, has further expanded its life science portfolio, by investing £2.5m in Cambridge-based Axol Bioscience (Axol), a provider of stem cells produced from reprogrammed human blood and tissue cells. Axol supplies the world’s top […]
La Vista, Neb. – Streck, Inc. and TK Biotech, a molecular biology and biotechnology of assisted reproduction products distributor in Poland, have signed a distribution agreement for Streck’s full portfolio of controls, cell stabilization and molecular products. Streck’s cell stabilization products include Cyto-Chex® BCT, a blood collection tube for the preservation of whole blood specimens […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
